Induction of S-phase Cell Cycle Arrest and Apoptosis in HeLa Cells by Small RNAs Fraction of Solanum tuberosum L.

Author(s): Sunny Yadav, Devashree Jahagirdar, Mamta Shekhawat, Nilesh Kumar Sharma*.

Journal Name: MicroRNA

Volume 8 , Issue 3 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: In cancer therapeutics, several new classes of small molecules based targeted drug options are reported including peptide mimetic and small RNAs therapeutics.

Objective: Small RNAs represent a class of short non-coding endogenous RNAs that play an important role in transcriptional and post transcriptional gene regulation among varied types of species including plants and animals.

Methods: To address the role of small RNAs from plant sources upon cancer cells, authors report on the effects of small RNAs fraction of potato in in-vitro model of human derived HeLa cancer cells. This paper reports the anti-proliferative and anti-survival effect of small RNAs fraction of S. tuberosum L. (potato) tuber tissue. Here, authors employed small RNAs fractionation protocol, cell viability, cell cytotoxicity MTT, PI stained cell cycle analysis and FITC-Annexin-V/PI stained apoptosis assays.

Results: In this paper, small RNAs fractions of potato clearly indicate 40-50% inhibition of HeLa cell proliferation and viability. Interestingly, flow cytometer data point out appreciable increase from 7% to 14% of S-phase in HeLa cells by displaying the presence of an S-phase cell cycle arrest. Further, arrest in S-phase of HeLa cells is also supported by an appreciable increase in total <2N plus >4N DNA containing HeLa cells over 2N containing HeLa cells. For apoptotic assay, data suggest a significant increase in apoptotic HeLa cells from (5%) control treated HeLa cells to (18%) small RNAs treated HeLa cells.

Conclusion: Taken together, findings suggest that small RNAs fractions of potato can induce Sphase cell cycle arrest and these agents can act as an anti-proliferative agent in HeLa cells. This paper proposes a huge scope for novel finding to dissect out the small RNAs target within HeLa cells and other cancer cell types.

Keywords: Apoptosis, cell proliferation, DNA replication, gene therapy, growth, targeted therapy.

[1]
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68(6): 394-424.
[2]
Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG. Cancer drug resistance: an evolving paradigm. Nat Rev Cancer 2013; 13(10): 714-26.
[3]
Farooqi AA, Rehman Z, Muntane J. Antisense therapeutics in oncology: current status. OncoTargets Ther 2014; 7: 2035-42.
[4]
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65(2): 87-108.
[5]
Ambros V, Bartel B, Bartel DP, et al. A uniform system for microRNA annotation. RNA 2003; 9: 277-9.
[6]
Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116(2): 281-97.
[7]
Fire AZ. Gene silencing by double-stranded RNA. Cell Death Differ 2007; 14(12): 1998-2012.
[8]
Mello CC. Return to the RNAi world: rethinking gene expression and evolution. Cell Death Differ 2007; 14(12): 2013-20.
[9]
Morris KV, Mattick JS. The rise of regulatory RNA. Nat Rev Genet 2014; 15(6): 423-37.
[10]
Kim HS, Lee KS, Bae HJ, et al. MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer. Oncotarget 2015; 6(10): 8089-102.
[11]
Shen SQ, Huang LS, Xiao XL, et al. miR-204 regulates the biological behavior of breast cancer MCF-7 cells by directly targeting FOXA1. Oncol Rep 2017; 38(1): 368-76.
[12]
Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001; 294(5543): 853-8.
[13]
Martin A, Adam H, Diaz-Mendoza M, et al. Graft-transmissible induction of potato tuberization by the microRNA miR172. Development 2009; 136: 2873-81.
[14]
Li F, Pignatta D, Bendix C, et al. MicroRNA regulation of plant innate immune receptors. Proc Natl Acad Sci USA 2012; 109: 1790-5.
[15]
Zhang R, Marshall D, Bryan GJ, Hornyik C. Identification and characterization of miRNA transcriptome in potato by high-throughput sequencing. PLoS One 2013; 8(2): e57233.
[16]
Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9: 654-9.
[17]
Wang K, Zhang S, Weber J, Baxter D, Galas DJ. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res 2010; 38: 7248-59.
[18]
Vickers KC, Remaley AT. Lipid-based carriers of microRNAs and intercellular communication. Curr Opin Lipidol 2012; 23: 91-7.
[19]
Eitan E, Zhang S, Witwer KW, et al. Extracellular vesicle-depleted fetal bovine and human sera have reduced capacity to support cell growth. J Extracell Vesicles 2015; 4: 26373.
[20]
Chin AR, Fong MY, Somlo G, et al. Cross-kingdom inhibition of breast cancer growth by plant miR159. Cell Res 2016; 26(2): 217-28.
[21]
Yadav S, Shekhawat M, Jahagirdar D, Sharma NK. Natural and artificial small RNAs: a promising avenue of nucleic acid therapeutics in cancer. Cancer Biol Med 2017; 14(3): 242-53.
[22]
LaMonte G, Philip N, Reardon J, et al. Translocation of sickle cell erythrocyte microRNAs into Plasmodium falciparum inhibits parasite translation and contributes to malaria resistance. Cell Host Microbe 2012; 12: 187-99.
[23]
Zhang L, Hou D, Chen X, et al. Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res 2012; 22: 107-11.
[24]
Lukasik A, Zielenkiewicz P. In silico identification of plant miRNAs in mammalian breast milk exosomes — a small step forward? PLoS One 2014; 9: e99963.
[25]
Liang G, Zhu Y, Sun B, et al. Assessing the survival of exogenous plant microRNA in mice. Food Sci Nutr 2014; 2: 380-8.
[26]
Liang H, Zhang S, Fu Z, et al. Effective detection and quantification of dietetically absorbed plant microRNAs in human plasma. J Nutr Biochem 2015; 26: 505-12.
[27]
Yang J, Farmer LM, Agyekum AA, Hirschi KD. Detection of dietary plant-based small RNAs in animals. Cell Res 2015; 25: 517-20.
[28]
Zhang H, Li Y, Liu Y, et al. Role of plant MicroRNA in cross-species regulatory networks of humans. BMC Syst Biol 2016; 10(1): 60.
[29]
Shekhawat M, Jahagirdar D, Yadav S, Sharma NK. Induction of apoptosis in HeLa by corn small RNAs. Nutr Cancer 2019; 1-11.
[http://dx.doi.org/10.1080/01635581.2018.1526307 [In press.]
[30]
Sharma NK, Kumar A, Kumari A, et al. Nitric oxide down-regulates topoisomerase I and induces camptothecin resistance in human breast MCF-7 tumor cells. PLoS One 2015; 10(11): e0141897.
[31]
Hughes DT, Sperandio V. Inter-kingdom signaling: communication between bacteria and their hosts. Nat Rev Microbiol 2008; 6(2): 111-20.
[32]
Chen X. Small RNAs in development - insights from plants. Curr Opin Genet Dev 2012; 22: 361-7.
[33]
Kornilov R, Puhka M, Mannerström B, et al. Efficient ultrafiltration-based protocol to deplete extracellular vesicles from fetal bovine serum. J Extracell Vesicles 2018; 7(1): 1422674.
[34]
Xu X, Hamhouyia F, Thomas SD, et al. Inhibition of DNA replication and induction of S phase cell cycle arrest by G-rich oligonucleotides. J Biol Chem 2001; 276(46): 43221-30.
[35]
Borel F, Lacroix FB, Margolis RL. Prolonged arrest of mammalian cells at the G1/S boundary results in permanent S phase stasis. J Cell Sci 2002; 115(Pt 14): 2829-38.
[36]
Shi Z, Azuma A, Sampath D. Li te-X,Huang P, and Plunkett W. S-Phase Arrest by Nucleoside Analogues and Abrogation of Survival without Cell Cycle Progression by 7-Hydroxystaurosporine1. Cancer Res 61: 1065-72.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 8
ISSUE: 3
Year: 2019
Page: [180 - 188]
Pages: 9
DOI: 10.2174/2211536608666181218114254
Price: $58

Article Metrics

PDF: 45
HTML: 5